KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Overview Fund Activity
Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

38 hedge funds and large institutions have $167M invested in Karuna Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+38
Holders Change %
–
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
38
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$36.5M
2
SI
2
Sofinnova Investments
California
$34.6M
3
EAM
3
Eventide Asset Management
Massachusetts
$22.1M
4
PHS
4
PFM Health Sciences
California
$14.2M
5
Sands Capital Management
5
Sands Capital Management
Virginia
$9.17M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
MS
26
Maven Securities
Jersey
$501K +$501K +25,000 New
FCM
27
Flinton Capital Management
Pennsylvania
$327K +$327K +20,468 New
TAM
28
Tyers Asset Management
Texas
$270K +$270K +16,856 New
Citigroup
29
Citigroup
New York
$230K +$230K +11,500 New
NA
30
Neuburgh Advisers
California
$212K +$212K +13,244 New
DCM
31
DAFNA Capital Management
California
$200K +$200K +10,000 New
Norges Bank
32
Norges Bank
Norway
$200K +$200K +10,000 New
MCIM
33
Meadow Creek Investment Management
Georgia
$154K +$154K +9,632 New
PIM
34
Partner Investment Management
California
$116K +$116K +7,219 New
FIA
35
FNY Investment Advisers
New York
$16K +$16K +811 New
RCM
36
Riverhead Capital Management
Delaware
$10K +$10K +642 New
Bank of America
37
Bank of America
North Carolina
$9K +$9K +448 New
CCA
38
Catalyst Capital Advisors
New York
$6K +$6K +310 New
1
2